Femcon FE Information

What's inside Femcon FE

Recent Femcon FE Side Effects

Posted by h2obabi28 1 day ago
I am in awe reading all of these comments and to the point of tears due to my new found emotional self. I just made an appoin...

Posted by yourmyhero16 1 day ago
I've Been Taking The Pill, I'd Say For About Three Months. I'm Sixteen Years Old. It Has Caused A Lot Of Problems For Me. I'v...

Posted by jules1286 1 day ago
I'm so glad I found this site. I have an IUD, but I have been talking Femcon FE for about 6 months because I had cysts on my ...

Femcon FE in the News

Warner Chilcott Reports Operating Results for the Quarter and Year ... - MSN Money
We introduced and began commercial sales of FEMCON FE in the second half of 2006, but did not initiate promotional efforts in support of the product until ...
Fri Feb 29 07:08:35 -0500 2008

Warner Chilcott Announces 2008 Financial Guidance - HispanicBusiness.com (press release)
Total revenues for 2008 are expected to be in the range of $935 to $945 million, with the growth primarily being driven by LOESTRIN 24 FE, DORYX, FEMCON FE, ...
Tue Jan 29 17:26:56 -0500 2008

Warner Chilcott Announces 2008 Financial Guidance - CNNMoney.com
Total revenues for 2008 are expected to be in the range of $935 to $945 million, with the growth primarily being driven by LOESTRIN 24 FE, DORYX, FEMCON FE, ...
Mon Jan 28 07:37:41 -0500 2008

Femcon FE Chemical Information

ethinyl estradiol - A semisynthetic estrogen. Ethinyl estradiol binds to the estrogen receptor complex and enters the nucleus, activating DNA transcription of genes involved in estrogenic cellular responses. This agent also inhibits 5-alpha reductase in epididymal tissue, which lowers testosterone levels and may delay progression of prostatic cancer. In addition to its antineoplastic effects, ethinyl estradiol protects against osteoporosis. In animal models, short-term therapy with this agent has been shown to provide long-term protection against breast cancer, mimicking the antitumor effects of pregnancy. (NCI04)

norethindrone - The acetate salt form of norethindrone, a synthetic progestational substance with some anabolic, estrogenic, and androgenic properties. Norethindrone binds to the progesterone intracellular receptors in the reproductive system and the resultant activated complex interacts with specific DNA sites. This leads to an alteration in protein synthesis and results in an inhibition of LH release. Consequently, it inhibits ovulation and changes the normal cycle of cervical mucus and endometrium.